G Yamanaka

Summary

Affiliation: Bristol-Myers Squibb
Country: USA

Publications

  1. ncbi Metabolic studies on BMS-200475, a new antiviral compound active against hepatitis B virus
    G Yamanaka
    Bristol Myers Squibb Pharmaceutical Research Institute, Wallingford, Connecticut 06492 7660, USA
    Antimicrob Agents Chemother 43:190-3. 1999
  2. ncbi Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase
    D J Tenney
    Department of Virology, Bristol Myers Squibb Pharmaceutical Research Institute, Wallingford, Connecticut 06492, USA
    Antimicrob Agents Chemother 41:2680-5. 1997
  3. ncbi Efficacies of entecavir against lamivudine-resistant hepatitis B virus replication and recombinant polymerases in vitro
    S Levine
    Bristol-Myers Squibb Pharmaceutical Research Institute, 5 Research Parkway, Wallingford, CT 06492, USA
    Antimicrob Agents Chemother 46:2525-32. 2002

Collaborators

  • R J Colonno
  • S Levine
  • D J Tenney
  • R Rose
  • D Hernandez
  • S Zhang
  • S Weinheimer
  • A V Tuomari
  • M Alam
  • A K Sheaffer
  • C W Cianci
  • S M Voss

Detail Information

Publications3

  1. ncbi Metabolic studies on BMS-200475, a new antiviral compound active against hepatitis B virus
    G Yamanaka
    Bristol Myers Squibb Pharmaceutical Research Institute, Wallingford, Connecticut 06492 7660, USA
    Antimicrob Agents Chemother 43:190-3. 1999
    ..Compared with five other nucleoside analogs of medical interest (lamivudine, penciclovir, ganciclovir, acyclovir, and lobucavir), BMS-200475 was most efficiently phosphorylated to the triphosphate in HepG2 cells...
  2. ncbi Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase
    D J Tenney
    Department of Virology, Bristol Myers Squibb Pharmaceutical Research Institute, Wallingford, Connecticut 06492, USA
    Antimicrob Agents Chemother 41:2680-5. 1997
    ..Furthermore, LBV may be effective in the treatment of GCV-resistant HCMV...
  3. ncbi Efficacies of entecavir against lamivudine-resistant hepatitis B virus replication and recombinant polymerases in vitro
    S Levine
    Bristol-Myers Squibb Pharmaceutical Research Institute, 5 Research Parkway, Wallingford, CT 06492, USA
    Antimicrob Agents Chemother 46:2525-32. 2002
    ..These findings are predictive of potent antiviral activity of ETV against both wild-type and 3TC-resistant HBV...